Inventor · Champaign, IL, US

Howard S. Roth

16Patents

6h-index

23Co-inventors

62Inventor score

Filing activity: Mar 6, 2013 → Aug 17, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US10919852B2	Immunomodulator compounds	Emerging Cross-Sectional Technologies	12	Active
US10392405B2	Macrocyclic immunomodulators	Chemistry; Metallurgy	11	Active
US9249116B2	Enzyme-activating compounds and compositions	Physics	9	Active
US11059834B2	Macrocyclic immunomodulators	Chemistry; Metallurgy	8	Active
US9663482B2	Substituted piperazinyl acetohydrazide procaspase-activating compounds	Physics	8	Active
US9399035B2	Procaspase 3 activation by combination therapy	Human Necessities	6	Active
US11485708B2	Compounds for treatment of PD-L1 diseases	Emerging Cross-Sectional Technologies	4	Active
US11691985B2	Macrocyclic immunomodulators	Chemistry; Metallurgy	2	Active
US11708326B2	Immunomodulator compounds	Emerging Cross-Sectional Technologies	2	Active
US11427541B2	Salt forms of a complement component C5A receptor	Chemistry; Metallurgy	1	Active
US12018016B2	Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors	Chemistry; Metallurgy	0	Active
US10888560B2	Procaspase 3 activation by combination therapy	Human Necessities	0	Active
US11833147B2	Procaspase 3 activation by combination therapy	Human Necessities	0	Active
US11872217B2	Indanes as PD-L1 inhibitors	Emerging Cross-Sectional Technologies	0	Active
US12012403B2	Aryl sulfonyl compounds as CCR6 inhibitors	Chemistry; Metallurgy	0	Active
US10085977B2	Procaspase 3 activation by combination therapy	Human Necessities	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.